Could an immune booster help fight colorectal cancer?
NCT ID NCT06557668
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study looks at whether adding an immunomodulator (a drug that helps the immune system) to standard cancer treatments can help people with colorectal cancer live longer. Researchers will compare survival and tumor response in 250 adults who received standard therapy with or without the immunomodulator. The goal is to see if this combination improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Chung-Shan Medical University Hospital
NOT_YET_RECRUITINGTaichung, Taiwan
-
Taichung Veterans General Hospital
RECRUITINGTaichung, Taiwan
Conditions
Explore the condition pages connected to this study.